Replies to post #677207 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

I agree with your explanation.

After seeing what’s happened in the DCVax-L GBM trial, I honestly don’t see how one can do a truly randomized trial of DCVax and include a crossover. To me, it’s obvious DCVax works… you typically don’t get recurrent GBM patients living as long as they did/do in the DCVax -L trial, and as the control patients in what had been a randomized trial, these were the patients that received the drug upon real progression, IMO.